V. Lawlis

V.
Bryan Lawlis was the founder of Covance Biotechnology Services, Inc., founded in 1996, serving as Chairman from 1999 to 2001.
Dr. Lawlis was the founder of Itero Biopharmaceuticals LLC, founded in 2006, serving as President & Chief Executive Officer from 2006 to 2011.
Dr. Lawlis was the founder of Itero Biopharmaceuticals, Inc., founded in 2007, serving as President & Chief Executive Officer from 2007 to 2011.
Current jobs include Director at Tspan LLC since 2017 and Director at Comera Life Sciences, Inc. Former jobs include Chief Executive Officer & Director at Aradigm Corp.
from 2005 to 2006; President & Chief Executive Officer at Itero Holdings LLC from 2011 to 2017; Director at Humanigen, Inc. from 2013 to 2014; Independent Director at Sutro Biopharma, Inc. from 2003 to 2019; Director at GlycoFi, Inc.; Independent Director at Geron Corp.
from 2012 to 2026; Independent Director at Coherus Oncology, Inc. from 2014 to 2021; Independent Director at Absci Corp.; Director at Comera Life Sciences Holdings, Inc.; Independent Non-Executive Director at BioMarin Pharmaceutical, Inc. from 2014 to 2024; Independent Director at Spyre Therapeutics, Inc. from 2018 to 2022; Vice President-Process Sciences at Genentech, Inc. from 1981 to 1996; Senior Scientist at Genencor International, Inc. in 1996.
Education includes undergraduate studies at The University of Texas at Austin and a doctorate from Washington State University conferred in 1979.